A3 adenosine receptor agonists companion diagnostic - Can-Fite BioPharma/Smart Assays

Drug Profile

A3 adenosine receptor agonists companion diagnostic - Can-Fite BioPharma/Smart Assays

Alternative Names: A3AR agonists companion diagnostic - Can-Fite BioPharma/Smart Assays; CF 101 companion diagnostic - Can-Fite BioPharma/Smart Assays; CF 102 companion diagnostic - Can-Fite BioPharma/Smart Assays; Namodenoson companion diagnostic - Can-Fite BioPharma/Smart Assays

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Can-Fite BioPharma; Smart Assays
  • Class Diagnostic agents
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Hepatocellular carcinoma; Rheumatoid arthritis

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Hepatocellular carcinoma(Diagnosis) in Israel
  • 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Rheumatoid-arthritis(Diagnosis) in Israel
  • 21 Apr 2014 Clinical in Hepatocellular carcinoma (diagnosis) in Israel (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top